...
首页> 外文期刊>Clinical Pharmacology and Therapeutics >The human placental perfusion model: a systematic review and development of a model to predict in vivo transfer of therapeutic drugs.
【24h】

The human placental perfusion model: a systematic review and development of a model to predict in vivo transfer of therapeutic drugs.

机译:人胎盘灌注模型:系统地回顾和发展模型,以预测治疗药物的体内转移。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Dual perfusion of a single placental lobule is the only experimental model to study human placental transfer of substances in organized placental tissue. To date, there has not been any attempt at a systematic evaluation of this model. The aim of this study was to systematically evaluate the perfusion model in predicting placental drug transfer and to develop a pharmacokinetic model to account for nonplacental pharmacokinetic parameters in the perfusion results. In general, the fetal-to-maternal drug concentration ratios matched well between placental perfusion experiments and in vivo samples taken at the time of delivery of the infant. After modeling for differences in maternal and fetaleonatal protein binding and blood pH, the perfusion results were able to accurately predict in vivo transfer at steady state (R(2) = 0.85, P < 0.0001). Placental perfusion experiments can be used to predict placental drug transfer when adjusting for extra parameters and can be useful for assessing drug therapy risks and benefits in pregnancy.
机译:单个胎盘小叶的双重灌注是研究人胎盘在组织化胎盘组织中物质转移的唯一实验模型。迄今为止,还没有尝试对该模型进行系统的评估。这项研究的目的是系统地评估预测胎盘药物转移的灌注模型,并开发一种药代动力学模型以说明灌注结果中的非胎盘药代动力学参数。通常,胎盘与母体药物的浓度比在胎盘灌注实验与婴儿分娩时采集的体内样本之间非常吻合。在对母体和胎儿/新生儿蛋白质结合和血液pH的差异进行建模后,灌注结果能够准确预测稳态下的体内转移(R(2)= 0.85,P <0.0001)。调整额外参数时,胎盘灌注实验可用于预测胎盘药物转移,并且可用于评估妊娠期药物治疗的风险和益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号